Furthermore, a set of genes that is directly regulated by FOXM1 and associated with poor prognosis in breast cancer18 showed significant correlation with poor clinical outcome in B-cell lineage ALL patients but not in myeloid lineage AML (Fig. 3e). Here, FOXM1 is linked to acute myeloid leukemia.